CoChat

Associations between Aβ deposition and neurometabolic alterations in Alzheimer's disease: Insights from hybrid 3D MRSI‐PET imaging

Zhang, Miao, Hu, Jialin, Zhang, Yaoyu, Meng, Ziyu, Zhao, Yibo, Li, Yudu, Jin, Wen, Qian, Xiao‐Hang, Wang, Lijun, Ye, Guanyu, Jiang, Xu‐Feng, Li, Ya‐Dong, Ye, Jian, Tang, Huidong, Liu, Jun, Nachev, Parashkev, Liang, Zhi‐Pei, Li, Biao, Li, Yao · 2025 · Alzheimer's & Dementia
Cited by 2

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Understanding the neurometabolic changes associated with amyloid‐β (Aβ) deposition is important for early Alzheimer's disease (AD) diagnosis, but their spatial relationships remained unexplored due to technical limitations. METHODS: We investigated the relationship between Aβ deposition and neuronal and glial metabolites using high‐resolution 3D magnetic resonance spectroscopic imaging (MRSI) (8‐min scan, 2 × 3 × 3 mm 3 resolution) and Aβ‐positron emission tomography (Aβ‐PET) imaging. N‐acetylaspartate, myo‐inositol, and creatine maps were obtained from 174 participants: 39 controls, 65 mild cognitive impairment (MCI), and 70 AD patients. RESULTS: N‐Acetylaspartate levels were negatively correlated with Aβ, while myo‐inositol levels were positively correlated globally. Regional associations with Aβ include N‐acetylaspartate reductions in frontal cortex, anterior cingulate cortex, and precuneus, and myo‐inositol increases in precuneus, lateral temporal, and lateral parietal cortices. Combined MRSI and PET biomarkers achieved the highest diagnostic accuracy for MCI and AD . DISCUSSION: Hybrid high‐resolution 3D MRSI and Aβ‐PET imaging provides valuable insights into Aβ’s impact on neurometabolic changes, improving early AD diagnosis. Highlights: Hybrid 3D magnetic resonance spectroscopic imaging–positron emission tomography (MRSI‐PET) imaging reveals Aβ deposition impact on neurometabolism in Alzheimer's disease (AD). N‐acetylaspartate (NAA) as a neuronal metabolic marker is negatively associated with Aβ globally and locally. Myo‐inositol (mI) as a glial metabolic marker is positively associated with Aβ globally and locally. Combining 3D magnetic resonance spectroscopic imaging (MRSI) and PET biomarkers improves diagnostic accuracy for mild cognitive impairment (MCI) and AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/alz.70332

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 46

  1. 10.1016/j.jalz.2011.03.003 · DOI · Paper page
  2. Kantarci K, 2008, Alzheimer Disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements, Riadology, 248, 210
  3. 10.1523/JNEUROSCI.2027-14.2014 · DOI · Paper page
  4. 10.1002/ana.25202 · DOI
  5. 10.1212/WNL.0000000000002672 · DOI
  6. 10.1212/WNL.0000000000006852 · DOI
  7. 10.1093/brain/awq208 · DOI
  8. 10.1212/WNL.0b013e31829a3329 · DOI · Paper page
  9. 10.1212/WNL.55.2.210 · DOI · Paper page
  10. 10.1212/WNL.58.6.928 · DOI · Paper page
  11. 10.1016/j.neurobiolaging.2016.08.022 · DOI
  12. 10.1016/j.neurobiolaging.2017.12.004 · DOI
  13. LiangZP.Spatiotemporal imaging with partially separable functions. In:2007 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro:IEEE.2007. p.988‐991. · DOI · Paper page
  14. 10.1002/mrm.25168 · DOI
  15. 10.1002/mrm.26019 · doi:10.1002/mrm.26019
  16. 10.1109/TBME.2017.2741922 · doi:10.1109/tbme.2017.2741922
  17. 10.1002/mrm.26972 · DOI
  18. 10.1002/mrm.27865 · DOI
  19. 10.1093/brain/awaa264 · DOI
  20. 10.1016/j.jalz.2011.03.005 · DOI · Paper page
  21. 10.1016/j.jalz.2011.03.008 · DOI · Paper page
  22. 10.2967/jnumed.115.166967 · DOI
  23. 10.1002/mrm.25635 · doi:10.1002/mrm.25635
  24. 10.1002/mrm.27980 · doi:10.1002/mrm.27980
  25. 10.1002/mrm.30200 · DOI
  26. Zhao Y, 2024, Ultrafast Magnetic Resonance Spectroscopic Imaging: Technical Development and Applications
  27. 10.1109/TBME.2012.2223466 · doi:10.1109/tbme.2012.2223466
  28. 10.1016/j.neuroimage.2006.01.021 · DOI · Paper page
  29. 10.2967/jnumed.110.076315 · DOI · Paper page
  30. 10.1007/s00259-014-2753-3 · DOI · Paper page
  31. Avants BB, 2009, Advanced normalization tools (ANTS), Insight J, 2, 1
  32. 10.2967/jnumed.114.148981 · DOI · Paper page
  33. 10.1126/sciadv.add2870 · DOI
  34. 10.1016/j.neuroimage.2020.116745 · DOI · Paper page
  35. MakalicE SchmidtDF.High‐dimensional Bayesian regularised regression with the BayesReg package.arXiv preprint arXiv:161106649.2016.
  36. Watanabe S., 2013, A widely applicable Bayesian information criterion, J Mach Learn Res, 14, 867
  37. 10.1212/WNL.0000000000002576 · DOI · Paper page
  38. 10.1007/s00259-013-2656-8 · DOI
  39. 10.1212/WNL.0b013e31822dc7e1 · DOI · Paper page
  40. 10.1016/j.neurobiolaging.2006.06.018 · DOI · Paper page
  41. 10.1016/S0140-6736(00)02246-7 · DOI · Paper page
  42. 10.1007/s00330-016-4669-8 · DOI
  43. 10.1097/00001756-200201210-00041 · DOI · Paper page
  44. Kantarci K, 2003, Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T, AJNR Am J Neuroradiol, 24, 843
  45. 10.1016/j.neurobiolaging.2014.07.030 · DOI · Paper page
  46. 10.1212/WNL.0000000000004421 · DOI

Cited by

See all 2

Metadata

Authors
Zhang, M., Hu, J., Zhang, Y., Meng, Z., Zhao, Y., Li, Y., Jin, W., Qian, X., Wang, L., Ye, G., Jiang, X., Li, Y., Ye, J., Tang, H., Liu, J., Nachev, P., Liang, Z., Li, B., & Li, Y.
Affiliations
  • Department of Nuclear Medicine Ruijin Hospital, School of Biomedical Engineering Shanghai Jiao Tong University Shanghai China
  • Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana‐Champaign Urbana Illinois USA
  • Department of Geriatrics Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
  • Department of Neurovascular Center Changhai Hospital Naval Medical University Shanghai China
  • Department of Neurology and Institute of Neurology Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China
  • Department of Gastroenterology, Songjiang Hospital and Songjiang Research Institute Shanghai Key Laboratory of Emotions and Affective Disorders, State Key Laboratory of Eye Health, Shanghai Jiao Tong University School of Medicine Shanghai China
  • High‐Dimensional Neurology Group, Institute of Neurology, University College London London UK
ORCID
Li, Yao
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2025-06
Volume
21
Issue
6
ISSN
  • 1552-5260
  • 1552-5279
Cited by
2
References
8
Language
en
Funders
  • National Natural Science Foundation of China (82372073, 82151314)
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
  • Science and Technology Commission of Shanghai Municipality (21ZR1481500)
  • Shanghai Municipal Health Commission (202240031)
  • Wellcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Associations between Aβ deposition and neurometabolic alterations in Alzheimer's disease: Insights from hybrid 3D MRSI‐PET imaging. https://app.cochat.ai/papers/10.1002/alz.70332
The paper
Zhang, M., Hu, J., Zhang, Y., Meng, Z., Zhao, Y., Li, Y., Jin, W., Qian, X., Wang, L., Ye, G., Jiang, X., Li, Y., Ye, J., Tang, H., Liu, J., Nachev, P., Liang, Z., Li, B., & Li, Y. (2025). Associations between Aβ deposition and neurometabolic alterations in Alzheimer's disease: Insights from hybrid 3D MRSI‐PET imaging. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70332

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.